Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Once again, Ranbaxy Laboratories may be facing a showdown with the FDA. The troubled generic drugmaker, which only recently agreed to pay $500 million to the US Department of Justice to settle criminal and civil charges associated with a long-running manufacturing scandal (see this), recently received a poor inspection report from the FDA for one of its facilities in India.
Help employers find you! Check out all the jobs and post your resume.
Once again, Ranbaxy Laboratories may be facing a showdown with the FDA. The troubled generic drugmaker, which only recently agreed to pay $500 million to the US Department of Justice to settle criminal and civil charges associated with a long-running manufacturing scandal (see this), recently received a poor inspection report from the FDA for one of its facilities in India.
Help employers find you! Check out all the jobs and post your resume.
